Bridgebio Pharma
BBIO65.3500.48% ( +0.310 )
已收盘: 10月9日 16:00:01 (美东)全部股东
股东类型
- 机构投资者85.84%
- 对冲基金10.27%
- 个人与内部人士3.84%
- 国有企业0.04%
- 私营企业<0.01%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Janus Henderson Group Ltd. | 7.22% | 1,411.03 万 | 0.48% | +93.13 万 | |
Farallon Capital Management, L.L.C. | 5.50% | 1,074.31 万 | 0.71% | +137.76 万 | |
BlackRock, Inc. | 5.26% | 1,028.72 万 | 2.00% | -392.06 万 | |
Viking Global Investors LP | 5.01% | 979.22 万 | 0.09% | -15.70 万 | |
Vanguard Capital Management, LLC | 4.61% | 901.60 万 | 0.05% | +8.13 万 | |
KKR & Co. Inc. | 4.23% | 826.10 万 | 2.56% | -500.00 万 | |
Vanguard Portfolio Management, LLC | 3.92% | 765.67 万 | 0.21% | -42.39 万 | |
Wellington Management Group LLP | 2.72% | 530.89 万 | 1.45% | +282.50 万 | |
Neil KumarCo-Founder, CEO & Director | 2.59% | 505.75 万 | 0.01% | -2.00 万 | |
Two Sigma Investments, LP | 2.42% | 472.22 万 | 0.82% | +160.16 万 | |
Aisling Capital Management LP | 2.35% | 458.96 万 | 0.25% | -50.00 万 | |
State Street Investment Management | 2.27% | 443.59 万 | 0.25% | -49.84 万 | |
Citadel Advisors LLC | 1.92% | 376.00 万 | 0.30% | +58.61 万 | |
D. E. Shaw & Co., L.P. | 1.86% | 363.30 万 | 0.56% | +108.75 万 | |
Invesco Ltd. | 1.80% | 351.94 万 | 0.47% | -91.62 万 | |
Geode Capital Management, LLC | 1.75% | 341.84 万 | 0.76% | -149.96 万 | |
Jane Street Group, LLC | 1.50% | 293.42 万 | 0.60% | +117.65 万 | |
Adage Capital Management, L.P. | 1.15% | 225.20 万 | 0.85% | +165.30 万 | |
UBS Asset Management AG | 1.14% | 223.69 万 | 0.10% | -19.29 万 | |
Franklin Templeton Inc. | 1.10% | 215.99 万 | 0.20% | +39.24 万 |